These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Jacobs MR; Good CE; Bajaksouzian S; Windau AR Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493 [TBL] [Abstract][Full Text] [Related]
30. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey. Gulay Z; Ozbek OA; Bicmen M; Gur D Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18. Su LH; Wu TL; Kuo AJ; Chia JH; Chiu CH J Antimicrob Chemother; 2009 Aug; 64(2):336-42. PubMed ID: 19520718 [TBL] [Abstract][Full Text] [Related]
32. Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. Hotomi M; Billal DS; Kamide Y; Kanesada K; Uno Y; Kudo F; Ito M; Kakehata S; Sugita R; Ogami M; Yamanaka N; J Clin Microbiol; 2008 Nov; 46(11):3808-10. PubMed ID: 18832131 [TBL] [Abstract][Full Text] [Related]
33. Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology. Dortet L; Ploy MC; Poyart C; Raymond J; Diagn Microbiol Infect Dis; 2009 Sep; 65(1):49-57. PubMed ID: 19679235 [TBL] [Abstract][Full Text] [Related]
34. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004). Shibl AM Clin Microbiol Infect; 2008 Sep; 14(9):876-9. PubMed ID: 18844690 [TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005. Thornsberry C; Brown NP; Draghi DC; Evangelista AT; Yee YC; Sahm DF Postgrad Med; 2008 Sep; 120(3 Suppl 1):32-8. PubMed ID: 18931469 [TBL] [Abstract][Full Text] [Related]
37. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472 [TBL] [Abstract][Full Text] [Related]
38. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637 [TBL] [Abstract][Full Text] [Related]
39. New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008). Imöhl M; Reinert RR; van der Linden M Int J Antimicrob Agents; 2009 Sep; 34(3):271-3. PubMed ID: 19419844 [TBL] [Abstract][Full Text] [Related]